Ascentage Pharma Group International (AAPG) Payables (2023 - 2026)

Ascentage Pharma Group International's Payables history runs 3 years deep, the most recent figure standing at $15.0 million for Q4 2025.

• In Q4 2025, Payables rose 17.55% year-over-year to $15.0 million; the TTM figure through Dec 2025 stood at $15.0 million (up 17.55% YoY), while the FY2025 annual figure was $14.9 million, up 16.01% from the prior year.
• Payables for Q4 2025 stood at $15.0 million, down from $16.6 million in the prior quarter.
• The five-year high for Payables was $16.6 million in Q2 2025, with the low at $10.1 million in Q4 2023.
• The 3-year median for Payables is $13.9 million (2024), against an average of $13.6 million.
• The sharpest annual moves came in 2024 and 2025: Payables gained 27.25% in 2024, then grew 17.55% in 2025.
• Ascentage Pharma Group International's Payables stood at $10.1 million in 2023, then increased by 27.25% to $12.8 million in 2024, then grew by 17.55% to $15.0 million in 2025.
• Business Quant data shows AAPG's Payables at $15.0 million in Q4 2025, $16.6 million in Q2 2025, and $12.8 million in Q4 2024.